Trials / Completed
CompletedNCT04697160
Observational Retrospective Cohort Study of Systemic Therapies for R/R DLBCL
An Observational Retrospective Cohort Study of Systemic Therapies for Relapsed or Refractory Diffuse Large B Cell Lymphoma (R/R DLBCL), to Compare Outcomes to Those From Tafasitamab + Lenalidomide in the L-MIND Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,573 (actual)
- Sponsor
- MorphoSys AG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To compare the efficacy outcomes of the L-MIND cohort with the effectiveness in a matched patient population treated with systemic NCCN/ESMO guideline listed regimens administered in routine clinical care.
Detailed description
This retrospective observational cohort study aims to generate a historical control consisting of R/R DLBCL patients who received currently guideline recommended therapies.
Conditions
Timeline
- Start date
- 2020-04-01
- Primary completion
- 2021-05-07
- Completion
- 2021-05-07
- First posted
- 2021-01-06
- Last updated
- 2021-10-20
Locations
165 sites across 12 countries: United States, Australia, Austria, Canada, Denmark, France, Germany, Italy, South Korea, Spain, Taiwan, United Kingdom
Source: ClinicalTrials.gov record NCT04697160. Inclusion in this directory is not an endorsement.